HBIO logo

Harvard Bioscience (HBIO)

Profile

Full Name

Harvard Bioscience, Inc.

Ticker Symbol

HBIO

Exchange

NASDAQ

Country

United States

IPO

March 19, 2001

Indexes

Not included

Employees

330

Key Details

Price

$0.39(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$94.14M(-16.14% YoY)

Annual EPS

-$0.28(-250.00% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Apr 9, 25 Keybanc
Sector Weight
Apr 8, 25 Keybanc
Sector Weight
Mar 24, 25 Benchmark
Speculative Buy
Jun 22, 23 Benchmark
Speculative Buy
Apr 26, 23 Keybanc
Overweight
Apr 26, 23 Benchmark
Buy
Mar 10, 23 Benchmark
Buy
Nov 9, 22 Keybanc
Overweight
Aug 5, 22 Keybanc
Overweight
Nov 10, 20 Keybanc
Overweight

Institutional Ownership

  • What is the ticker symbol for Harvard Bioscience?
  • Does Harvard Bioscience pay dividends?
  • What sector is Harvard Bioscience in?
  • What industry is Harvard Bioscience in?
  • What country is Harvard Bioscience based in?
  • When did Harvard Bioscience go public?
  • Is Harvard Bioscience in the S&P 500?
  • Is Harvard Bioscience in the NASDAQ 100?
  • Is Harvard Bioscience in the Dow Jones?
  • When was Harvard Bioscience's last earnings report?
  • When does Harvard Bioscience report earnings?
  • Should I buy Harvard Bioscience stock now?

What is the ticker symbol for Harvard Bioscience?

The ticker symbol for Harvard Bioscience is NASDAQ:HBIO

Does Harvard Bioscience pay dividends?

No, Harvard Bioscience does not pay dividends

What sector is Harvard Bioscience in?

Harvard Bioscience is in the Healthcare sector

What industry is Harvard Bioscience in?

Harvard Bioscience is in the Medical Instruments & Supplies industry

What country is Harvard Bioscience based in?

Harvard Bioscience is headquartered in United States

When did Harvard Bioscience go public?

Harvard Bioscience's initial public offering (IPO) was on March 19, 2001

Is Harvard Bioscience in the S&P 500?

No, Harvard Bioscience is not included in the S&P 500 index

Is Harvard Bioscience in the NASDAQ 100?

No, Harvard Bioscience is not included in the NASDAQ 100 index

Is Harvard Bioscience in the Dow Jones?

No, Harvard Bioscience is not included in the Dow Jones index

When was Harvard Bioscience's last earnings report?

Harvard Bioscience's most recent earnings report was on Mar 12, 2025

When does Harvard Bioscience report earnings?

The next expected earnings date for Harvard Bioscience is May 7, 2025

Should I buy Harvard Bioscience stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page